-
Bible J M, Iturriza-Gomara M, Megson B. Molecular epidemiology of human enterovirus71 in the UnitedKingdomfrom1998 to 2006[J]. J Clin Microbiol, 2006, 46(): 3192-3200.
-
Brown B A, Oberste M S, Alexander Jr J P. Molecular epidemiology and evolution of enterovirus71 strains isolated from1970 to 1998[J]. J Virol, 1999, 73(12): 9969-9975.
-
Chan Y F, Sam I-Ch, AbuBaka S. Phylogenetic designation of enterovirus 71 genotype sand subgenotype susing complete genome sequences[J]. Infect Genet Evol, 2010, 10(): 404-412. doi: 10.1016/j.meegid.2009.05.010
-
Chen H L, Huang J Y, Chu T W. Expression of VP1 protein in the milk of transgenic mice: A potential oral vaccine protects against enterovirus 71 infection[J]. Vaccine, 2008, 26(23): 2882-2889. doi: 10.1016/j.vaccine.2008.03.041
-
Chumakov M, Voroshilova M, Shindarov L. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria[J]. Arch Virol, 1979, 60(): 329-340. doi: 10.1007/BF01317504
-
Diedrich S, Weinbrecht A, Schreier E. Seropreva lence and molecula repidemiology of enterovirus71 in Germany[J]. Arch Virol, 2009, 154(): 1139-1142. doi: 10.1007/s00705-009-0413-x
-
Foo D G, Alonso S, Phoon M C. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides[J]. Virus Res, 2007, 125(): 61-68. doi: 10.1016/j.virusres.2006.12.005
-
He Y H, Yang F, Li C L. Identification of EV71 isolates from hand, foot and mouth disease cases in Shenzhen[J]. Chin J Exp Clin Virol, 1999, 1(): 112-.
-
Li X L, Mao C M, Ma S J. Generation of neutralizing monoclonal antibodies against Enterovirus71 using syntheticpeptides[J]. Biochem Biophys Res Commun, 2009, 390(): 1126-1128. doi: 10.1016/j.bbrc.2009.09.103
-
Moore D M, Cowan K M. Effect of trypsin and chymotrypsin on the polypeptides of large and small plaque variants of foot-and-mouth disease virus: relationship to specific antigenicity and infectivity[J]. J Gen Virol, 1978, 41(): 549-562. doi: 10.1099/0022-1317-41-3-549
-
Ortner B, Huang C W, Schmid D. Epidemiology of entero-virus types causing neurological disease in Austria 1999â€"2007: detection of clusters of echovirus30 and enterovirus71 and anal-ysis of prevalent genotypes[J]. J Med Virol, 2009, 81(): 317-324. doi: 10.1002/jmv.v81:2
-
Peter C M. An overview of the evolution of enterovirus 71 and its clinical and public health significance[J]. FEMS Microbiol Rev, 2002, 26(): 91-107. doi: 10.1111/j.1574-6976.2002.tb00601.x
-
Peter M, Katie L, David P. Phylogenetic Analysis of Enterovirus 71 Strains Isolated during Linked Epidemics in Malaysia, Singapore, and Western Australia[J]. J Virol, 2001, 75(): 7732-7738. doi: 10.1128/JVI.75.16.7732-7738.2001
-
Sanders S A, Herrero L J, McPhie K. Molecular epidemiology of enterovirus71 over two decades in an Australian urban community[J]. Arch Virol, 2006, 151(): 1003-1013. doi: 10.1007/s00705-005-0684-9
-
Shih S R, Li Y S, shuen P C. Expression of capsid protein VP1 for use as antigen for the diagnosis of enterovirus 71 infection[J]. J Med Virol, 2000, 61(): 228-34. doi: 10.1002/(ISSN)1096-9071
-
Tung W S, Bakar S A, Sekawi Z. DNA vaccine constructs against enterovirus 71 elicit immune response in mice[J]. Genet Vaccines Ther, 2007, 5(): 6-. doi: 10.1186/1479-0556-5-6
-
Yu H Y, Chen W, Chang H Y. Genetic anylysis of the VP1 region of ecterovirus 71 reveals the emergence of genotype A in central China in 2008[J]. Virus genes, 2010, 41(): 1-4. doi: 10.1007/s11262-010-0472-9
-
Zhou S L, Li L L, He Y Q. Expression of VP1 of Enterovirus 71 in E. coli[J]. J Anal Sci, 2007, 23(): 157-159. doi: 10.2116/analsci.23.157